Cytomegalovirus infection associated accelerated heart allograft arteriosclerosis may impair the late function of the graft

Clinical Transplantation

Volumn 10, Issue 6 I, 1996, Pages 487-493

  Koskinen, Petri ^a,c   Lemstrøm, Karl ^a   Mattila, Severi ^b   Häyry, Pekka ^a   Nieminen, Markku S ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Transplantation Laboratory   (Finland)

Author keywords

Angiography; CMV infection; Echocardiography; Heart allograft arteriosclerosis; Heart transplantation

Indexed keywords

ANTIVIRUS AGENT; CYTOMEGALOVIRUS ANTIBODY; GANCICLOVIR;

ANGIOCARDIOGRAPHY; ARTERIOSCLEROSIS; ARTICLE; CYTOMEGALOVIRUS INFECTION; ECHOCARDIOGRAPHY; GRAFT REJECTION; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HEART TRANSPLANTATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ACUTE DISEASE; CARDIAC OUTPUT, LOW; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY DISEASE; CORONARY VESSELS; CYTOMEGALOVIRUS INFECTIONS; ECHOCARDIOGRAPHY; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HEART VENTRICLES; HUMANS; STROKE VOLUME; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030467081     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. GAO SZ, ALDERMAN EL, SHROEDER JS, SILVERMAN JF, HUNT SA. Accelerated coronary vascular disease in the heart transplant patient. Coronary arteriographic findings. J Am Coll Cardiol 1988; 12: 334
2. UYS CJ, ROSE AG. Pathologic findings in long-term cardiac transplants. Arch Pathol Lab Med 1984; 108: 112
3. BILLINGHAM ME. Cardiac transplant atherosclerosis. Transpl Proc 1987; 19:19
4. HRUBAN RH, BESCHORNER WE, BAUMGARTNER WA, AUGUSTINE SM, REN H. REITZ BA. HUTCHINS GM. Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis. Am J Pathol 1990; 137: 871
5. WREGHITT TG, HAKIM M, GRAY JJ, et al. Cytomegalovirus infections in heart and heart and lung transplant recipients. J Clin Pathol 1988; 41: 660
6. VAN DEN BERG AP, TEGZESS AM, SCHOLTEN-SAMPSON A, et al. Monitoring antigenemia is useful in guiding treatment of severe cytomegalovirus disease after organ transslantation. Transpl Int 1992; 5: 101
7. THE TH, VAN DER PLOEG M, VAN DEN BERG AR, VLIEGER AM, VAN DER GIESSEN VAN SON WJ. Direct detection of cytomegalovirus in peripheral blood leukocytes-a review of the antigenemia assay and polymerase chain reaction. Transplantation 1992; 54: 193
8. DUMMER JS, WHITE LT, HO M, et al. Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine. J Infect Dis 1985; 152: 1182
9. GRATTAN MT, MORENO-CABRAL CE, STARNES VA, et al. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. J Am Med Assoc 1989; 261: 3561
10. MCDONALD K, RECTOR TS, BRAUNLIN EA, KUBO SH, OLIVARI MT. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol 1989; 64: 359
11. WREGHITT T. Cytomegalovirus infections in heart and heart-lung transplant recipients. J Antimicrob Chemother 1989; 23 (Suppl E): 49
12. LOEBE M, SCHUELE, ZAIS O, et al. Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J Heart Transpl 1990; 9: 707
13. EVERETT JP, HERSHBERGER RE, NORMAN DJ, et al. Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. J Heart Lung Transpl 1992; 11: S133
14. KOSKINEN PK, NIEMINEN MS, KROGERUS LA, et al. Cytomegalovirus infection accelerates cardiac allograft vasculopathy: correlation between angiographic and endomyocardial findings in heart transplant patients. Transpl Int 1993; 6: 341
15. BILLINGHAM ME, NATHANIEL RB, CARY NRB, et al. A working formulation of the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Lung Transpl 1990: R- 587
16. VAN DER BIJ W. TORENSMA R. VAN SON WJ, et al. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leukocytes. J Med Virol 1988; 25: 179
17. TIECHOLTZ LE, KREUVEN T, HERMAN MU, GORDIN R. Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol 1976; 37: 7
18. MIN KW, WICKEMEYER WJ, CHANDRAN P, et al. Fatal cytomegalovirus infection and coronary arterial thromboses after heart transplantation: a case report. J Heart Transpl 1987; 6:100
19. KOSKINEN PK, KROGERUS LA, NIEMINEN MS, et al. Quantitation of cytomegalovirus infection-associated histologic findings in endomyocardial biopsies of heart allografts. J Heart Lung Transpl 1993; 12: 343
20. DODD DA, BRADY LD, GARDEN KA, et al. Pattern of echocardiographic abnormalities with acute cardiac allograft rejection in adults: Correlation with endomyocardial biopsy. J Heart Lung Transpl 1993; 12: 1009
21. COLLINGS CA, PINTO FJ, VALANTINE HA, et al. Exercise echocardiography in heart transplant recipients: a comparison with angiography and intracoronary ultrasonography. J Heart Lung Transpl 1994; 13: 604
22. SPEIR E, MODALI R, HUANG E-S, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994; 265: 391
23. TUMILOWICZ JJ, GAWLIK ME, POWELL BB, TRENTIN JJ. Replication of cytomegalovirus in human arterial smooth muscle cells. J Virol 1985; 56: 839
24. MELNICK JL, DREESMAN GR, MCCOLLUM CH, et al. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 1983; 11: 644
25. HENDRIX MGR, DORMANS PHJ, KITSLAAR P. BOSMAN F. BRUGGEMAN CA. The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and non-atherosclerotics patients. Am J Pathol 1989; 134: 1151
26. HENDRIX MGR, SALIMANS MMM, VAN BOVEN CPA, BRUGGEMAN CA. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 1990; 136: 23
27. HENDRIX MGR, DAEMEN M, BRUGGEMAN CA. Cytomegalovirus nucleic acids distribution within the human vascular three. Am J Pathol 1991; 138: 563
28. BENDITT EP, BARRETT T, DOUGALL JK. Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci USA 1983; 80: 6386
29. MELNICK JL, ADAM E, DEBAKEY ME. Possible role of cytomegalovirus in atheroqenesis. J Am Med Soc 1990; 263: 2204
30. GREFTE JMM, VAN DER GUN BTF, SCHMOLKE S. et al. The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. J Gen Virol 1992; 73: 2923
31. RICE GPA, SCHRIER RD, OLDSTONE MBA. Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products: Proc Natl Acad Sci USA 1984; 81: 6134
32. SCHRIER RD, NELSON JA, OLDSTONE MBA. Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science 1985; 230: 1048
33. SPAN AHM, GRAULS G, BOSMAN F, VAN BOVEN CPA, BRUGGEMAN CA. Cytomegalovirus infection induces vascular injury in the rat. Atherosclerosis 1992; 93: 41
34. FREDMAN HM, MACARAK EJ, MACGREGOR RR, WOLFE J. KEFALIDES NA. Virus infection of endothelial cells. J Inf Dis 1981; 143: 266
35. SMILEY ML, MAR E-C, HUANG E-S. Cytomegalovirus infection and viralinduced transformation of human endothelial cells. J Med Virol 1988; 25: 213
36. PERCIVALLE E, REVELLO MG, VAGO L, MORINIO F, GERNA G. Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement. J Clin Invest 1993; 92: 663
37. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801
38. + T cells. Transplantation 1993; 56: 1504
39. HRUBAN RH, Wu T-C, BESCHORNER WE, et al. Cytomegalovirus nucleic acids in allografted hearts. Human Pathol 1990; 21: 981
40. VON WILLEBRAND E, PETTERSSON E, AHONEN J. HAYRY P. CMV infection, class II expression, and human kidney allograft rejection. Transplantation 1986; 42: 364
41. KELLER RR, PEITCHEL JN, GOLDMAN JN, GOLDMAN M. An IgG-Fc receptor induced in cytomegalovirus-infected human fibroblasts. J Immunol 1976; 116: 772
42. MACGREGOR RR, FRIEDMAN HM, MACARAK EJ, KEFALIDES NA. Virus infection of endothelial cells increases granulocyte adherence. J Clin Invest 1980; 65: 1469
43. FUJINAMI RS, NELSON JA, WALKER L, OLDSTONE MBA. Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR β chain: a means for graft rejection and immunosuppression. J Virol 1988; 62: 100.
44. USTINOV J, LOGINOV R, BRUGGEMAN CA, et al. Cytomegalovirus induces class II expression in rat heart endothelial cells. J Heart Lung Transpl 1993. 12: 644
45. BECK S, BARRELL BG. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-1 antigens. Nature 1988; 331: 269
46. KOSKINEN PK. The association of the induction of vascular cell adhesion molecule-I with cytomegalovirus antigenemia in human heart allografts. Transplantation 1993; 56: 1103
47. Ross R, WIGHT TN, SRANDNESS E, THIELE B. Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol 1984; 114: 79.